Company / Working Capital per Share
Barinthus Biotherapeutics plc. Working Capital per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$1.68
FY2025
5-year range
$1.68 / $27.08
FY2021-FY2025
Trend
-40.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has declined for 4 consecutive years, from $27.08 in FY2021 to $1.68 in FY2025.
Based on SEC 10-K filings.
1.68 in FY2025 with a 3-year CAGR of -32.2%.
Declined from $3.83 to $1.68 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -32.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Barinthus Biotherapeutics plc.'s working capital per share has declined for 4 consecutive years.
- In FY2025, working capital per share decreased 40.9% year-over-year.
- Peak working capital per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.68 | -40.9% |
| FY2024 | $2.85 | -25.6% |
| FY2023 | $3.83 | -29.1% |
| FY2022 | $5.40 | -80.1% |
| FY2021 | $27.08 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026